Hypothryroidism is a is a chronic condition in which you have an underactive thyroid where it does not produce enough thyroid hormones. touchENDOCRINOLOGY were delighted to speak with Dr Giulia Brigante (University of Modena and Reggio Emilia, Modena, Italy) about the challenges of treating patients with hypothryroidism.
The abstract ‘RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL ON LEVOTHYROXINE AND LIOTHYRONINE COMBINATION THERAPY: THE LEVOLIO STUDY‘ was presented at the European Congress of Endocrinology (ECE), 13-16 May 2023.
- What are the challenges of treating patients with hypothryroidism? (0:20)
Disclosures: Giulia Brigante is a consultant for Prolevi Bio.
Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Shanice Allen.
Filmed in coverage of the European Congress of Endocrinology (ECE) Annual Meeting
Click here for more content on thyroid disorders.
I’m Giulia Brigante. I’m an endocrinologist. I work as a researcher at the Unit of Endocrinology of the University of Moderna and Reggio Emilia in Italy.
What are the challenges of treating patients with hypothryroidism?
The treatment of hypothyroidism is theoretically quite simple because it is based on the administration of thyroid hormone, thyroxine, which then is activated at the tissue level by deiodinases. But in real life, this mechanism doesn’t seem to be equally efficient in all tissues and in all subjects. Clinical practice and also several studies demonstrated that up to ten, twenty percent of hypothyroid patients treated with this hormone complain of hypothyroidism symptoms despite normal serum TSH levels. We still have to understand which patients should need something more than levothyroxine E alone to recreate a physiological thyroid situation.
Subtitles and transcript are autogenerated.
Share this Video
Related Videos In Thyroid Disorders
Sina Jasim, ENDO23: Cytologic and Molecular Assessment of Isthmus Thyroid Nodules
Thyroid nodules arising in the isthmus are more likely to be malignant and demonstrate more aggressive behavior relative to thyroid nodules from either thyroid lobe. touchENDOCRINOLOGY were joined by Dr Sina Jasim (Washington University, St Louis, MO, USA) to discuss the main findings of her study presented at ENDO23. The abstract ‘THU-680 – Cytologic And […]
Updated guidelines for the management of primary hyperparathyroidism: Aliya Khan, WCO-IOF-ESCEO 2023
Surgery remains a mainstay of treatment in primary hyperparathyroidism (PHPT), the new guidelines for management provide alternative options for patients in which surgery is contraindicated. We were delighted to speak to Prof. Aliya A. Khan (McMaster University Medical Centre, Hamilton, Canada) around the current management of PHPT, the updates to management in the new guidelines […]
Symptoms, diagnosis and complications in primary hyperparathyroidism: Aliya Khan, WCO-IOF-ESCEO 2023
Primary hyperparathyroidism (PHPT) is caused by the overproduction of parathyroid hormone (PTH) by the parathyroid gland, the symptoms of which can remain dormant until later in life and as such PHPT is often underdiagnosed. We were delighted to speak to Prof. Aliya A. Khan (McMaster University Medical Centre, Hamilton, Canada) around the presentation of PHPT, […]
Journal articles and more to your inbox
Get the latest clinical insights from touchENDOCRINOLOGYSign me up!